Market Outlook

By 2035, the U.S. Portable Patient Monitoring Devices Market is expected to reach approximately USD 11.56 billion, expanding at a CAGR of 9.60% during the forecast period 2026-2035. The market was valued at USD 4.62 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions. The estimate covers medical-grade portable, handheld, transportable, and wearable monitoring devices, associated sensors, and embedded connectivity used in clinical care. It excludes fixed bedside systems, implantable monitors, therapeutic devices, software-only platforms, and consumer wellness wearables that are not deployed for medical decision-making.

The U.S. market is moving from episodic vital-sign measurement toward continuous, mobile, and distributed surveillance. Portable multiparameter monitors remain essential in emergency departments, transport, perioperative care, step-down units, ambulances, and temporary care areas, while wearable biosensors, ambulatory ECG devices, connected pulse oximeters, blood pressure monitors, capnography systems, and remote physiologic monitoring kits are extending observation beyond the conventional bedside. This shift is commercially important because it expands the addressable market from a finite installed base of hospital monitors to a recurring ecosystem of sensors, patches, cuffs, electrodes, disposables, device-management services, and replacement cycles.

Historical market value increased from approximately USD 3.12 billion in 2021 to USD 3.43 billion in 2022, USD 3.78 billion in 2023, and USD 4.18 billion in 2024 before reaching USD 4.62 billion in 2025. Growth during this period reflected normalization of hospital capital spending after the pandemic, sustained investment in telemetry and transport monitoring, the expansion of hospital-at-home programs, wider use of ambulatory cardiac monitoring, and stronger reimbursement support for remote physiologic monitoring. Demand also benefited from a large national care-delivery base that includes more than 6,000 hospitals, over 900,000 staffed beds, and more than 34 million annual hospital admissions.

The forecast assumes a measured replacement cycle for hospital-owned portable monitors, faster adoption of wireless wearable systems, increasing use of remote monitoring for acute and chronic conditions, and higher sensor revenue per monitored patient. The strongest commercial growth will come from products that reduce manual vital-sign rounds, support early deterioration detection, preserve patient mobility, integrate with electronic health records, and allow health systems to monitor patients across inpatient, outpatient, post-acute, and home settings. Aggressive growth will be moderated by alarm burden, device interoperability gaps, cybersecurity obligations, clinician workflow constraints, reimbursement compliance, and the need to prove that monitoring data changes clinical decisions rather than merely increasing data volume.

Introduction

According to the U.S. Portable Patient Monitoring Devices Market Report, the industry sits at the intersection of medical device hardware, clinical surveillance, digital health, and care-delivery redesign. Portable monitoring is no longer limited to a wheeled monitor transferred with a patient between departments. The category now includes compact multiparameter systems, handheld spot-check monitors, wearable telemetry, patch-based sensors, ambulatory ECG recorders, mobile pulse oximetry, noninvasive blood pressure devices, portable capnography, temperature monitoring, selected glucose-monitoring devices, and connected home kits that automatically transmit physiologic data to clinicians.

The clinical rationale is reinforced by the scale of chronic disease in the United States. More than 194 million U.S. adults report at least one chronic condition, nearly half of adults have hypertension, approximately 40 million people live with diabetes, and cardiovascular disease remains a leading cause of death. Respiratory disease also creates a substantial monitoring need, with diagnosed COPD prevalence rising sharply with age and reaching double-digit levels among the oldest adults. These conditions require repeated measurement of blood pressure, oxygen saturation, heart rhythm, respiratory rate, glucose, weight, temperature, and activity to identify deterioration before it becomes an emergency admission.

The market also reflects hospital workflow economics. Nursing labor is the largest operating expense for most health systems, and repeated manual vital-sign collection consumes time that could otherwise be directed toward assessment, medication administration, discharge planning, and patient education. Portable and wearable systems can improve surveillance coverage, but procurement decisions are increasingly based on total workflow impact. Buyers evaluate alarm specificity, battery life, cleaning burden, consumable cost, network reliability, device fleet management, cybersecurity, interoperability, and the amount of clinician time required to review data. A technically capable monitor can still fail commercially if it creates excessive false alarms, duplicates documentation, or requires a separate dashboard that clinicians rarely open.

For market sizing, the report uses a bottom-up model combining U.S. device shipments, installed-base replacement cycles, estimated hospital and ambulatory penetration, home-monitoring enrollment, average selling prices, sensor attach rates, and recurring disposable revenue. The model distinguishes medical-grade patient monitoring from consumer wellness tracking and avoids double counting software and clinical services. This scope is important because remote patient monitoring market estimates often include platforms, care-management labor, telehealth services, and analytics, while this report concentrates on the physical devices and directly associated monitoring sensors that generate physiologic data.

Key Market Drivers: What’s Fueling the U.S. Portable Patient Monitoring Devices Market Boom?

The first major driver is the growing burden of chronic and multimorbid disease. Approximately six in ten younger adults, eight in ten midlife adults, and nine in ten older adults report at least one chronic condition. Portable monitoring becomes more valuable as patients accumulate multiple conditions because a single episode may require simultaneous observation of blood pressure, pulse, oxygen saturation, respiratory rate, weight, glucose, and rhythm. The commercial opportunity therefore extends beyond single-disease programs. Health systems increasingly seek configurable platforms that can support hypertension, heart failure, diabetes, COPD, post-surgical recovery, oncology, renal disease, and geriatric care using a common connectivity and clinical-review architecture.

A second driver is population aging. The U.S. population age 65 and older reached more than 61 million in 2024 and is growing faster than the population overall. Older adults account for a disproportionate share of hospital admissions, cardiovascular events, respiratory disease, diabetes complications, falls, surgery, and post-acute care. They are also more likely to require monitoring during transitions between hospital, rehabilitation, skilled nursing, home health, and physician follow-up. Device manufacturers that simplify setup, reduce charging requirements, use large displays, provide automatic data transmission, and minimize patient interaction are better positioned for this population than products that depend on frequent app navigation or manual pairing.

A third driver is the institutional shift toward lower-acuity and decentralized care. The CMS Acute Hospital Care at Home initiative has approved hundreds of facilities across more than one hundred health systems and dozens of states. Hospital-at-home models require reliable portable monitoring because clinical teams must reproduce selected elements of inpatient surveillance without continuous physical presence. Similar requirements exist in ambulatory surgery, urgent care, infusion centers, dialysis, home health, and skilled nursing. The more care moves away from a fully equipped bedside, the more valuable compact monitors, wearable sensors, cellular connectivity, remote device management, and escalation algorithms become.

A fourth driver is Medicare and commercial reimbursement for remote physiologic monitoring. CMS broadly covers collection of physiologic data for acute and chronic conditions when requirements are met, and the monitoring device must satisfy the FDA definition of a medical device and automatically upload data to a secure location. The reimbursement pathway has encouraged physician groups, health systems, digital health companies, and home-care providers to deploy connected blood pressure cuffs, scales, pulse oximeters, glucose devices, and other monitoring tools. Reimbursement does not guarantee program profitability, however. Successful models require patient enrollment, device logistics, adherence, clinical staffing, documented treatment management, and control of churn and unreturned devices.

A fifth driver is the need to detect deterioration earlier in general-care environments. Many hospital adverse events occur outside the intensive care unit, where patients may be checked intermittently rather than continuously. Wireless wearable monitors allow surveillance without tethering patients to a bedside, supporting ambulation and potentially identifying rising respiratory rate, declining oxygen saturation, tachycardia, fever, or reduced activity before overt deterioration. Hospitals are especially interested in scalable solutions that can expand monitoring coverage during census surges without converting every bed into a traditional high-acuity monitored bed.

A sixth driver is the economics of hospital capacity and patient flow. Portable monitors help maintain observation during transport, emergency department boarding, diagnostic procedures, recovery, and transfer between units. Their value increases when bed availability is constrained and patients spend longer periods in nontraditional locations. Health systems are using command centers, centralized telemetry, and virtual nursing to manage capacity across multiple facilities. Portable devices that stream standardized data into these operational systems can support faster escalation, more consistent surveillance, and smoother movement through the hospital.

A seventh driver is the growth of ambulatory cardiac and respiratory monitoring. Cardiac monitoring has one of the clearest clinical and reimbursement pathways because arrhythmias are intermittent and often missed by short in-office testing. Patch monitors, mobile cardiac telemetry, handheld ECG devices, and extended Holter systems have expanded monitoring duration and patient convenience. Respiratory monitoring is also growing through connected pulse oximetry, portable capnography, wearable respiratory-rate sensors, and home devices used for COPD, sleep-related risk, post-discharge surveillance, and opioid safety.

An eighth driver is procurement preference for platform standardization. Large integrated delivery networks increasingly want a consistent monitoring ecosystem across emergency care, operating rooms, intensive care, medical-surgical units, transport, ambulatory sites, and home programs. Platform standardization can reduce training variation, simplify accessories and sensors, improve cybersecurity management, and strengthen enterprise contracting. This favors manufacturers with broad portfolios, but it also creates opportunities for specialized innovators that integrate cleanly with dominant central stations, electronic records, and mobile clinical communication tools.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. portable patient monitoring devices market is increasingly centered on clinical usability rather than measurement capability alone. Accurate heart rate, blood pressure, oxygen saturation, temperature, and respiratory rate are necessary, but they are no longer sufficient differentiators. Manufacturers are competing on the ability to acquire reliable data during motion and low perfusion, maintain wireless connectivity, reduce artifact, prioritize clinically meaningful alerts, and make the device disappear into the workflow. The winning product is likely to be the one that produces fewer unnecessary interventions while preserving confidence when a true change occurs.

Wearable multiparameter monitoring is one of the most important innovation cycles. New chest patches, wrist devices, adhesive sensors, and lightweight telemetry monitors can collect continuous physiologic data while allowing the patient to walk, sleep, rehabilitate, or recover at home. The design challenge is balancing battery life, sensor adhesion, skin tolerance, signal quality, and transmission reliability. Devices that can operate for multiple days without charging or replacement reduce nursing workload and improve home-program adherence. Disposable and semi-disposable models also create recurring revenue, but purchasers closely examine per-patient cost and environmental waste.

Artificial intelligence and predictive analytics are becoming a strategic layer across the category. Algorithms can combine trends in respiratory rate, oxygen saturation, pulse, temperature, activity, and posture to identify patterns that may precede deterioration. The commercial value is not simply an algorithm score. It is the ability to route the right alert to the right clinician, explain the reason for the alert, integrate it with existing early warning protocols, and document the response. Hospitals are cautious about black-box predictions and expect validation across diverse patient populations, care settings, skin tones, ages, and disease states.

Sensor innovation is also improving performance in difficult clinical conditions. Pulse oximetry companies continue to address accuracy during motion, low perfusion, and variable skin pigmentation. Noninvasive blood pressure technologies are being optimized for ambulatory use and repeated measurement. Portable capnography is becoming more compact for procedural sedation, transport, emergency medicine, and opioid monitoring. Ambulatory ECG devices are extending wear time while reducing device size and patient burden. Continuous temperature and respiratory-rate sensing are being integrated into wearable platforms to create a broader physiologic picture.

Connectivity is moving from accessory to core architecture. Bluetooth remains common for short-range device-to-hub communication, while Wi-Fi supports hospital network integration and cellular connectivity is increasingly important for home and mobile care. Manufacturers are adding automatic provisioning, over-the-air updates, device location, battery-status monitoring, and fleet analytics. These capabilities help biomedical engineering and clinical engineering teams manage thousands of distributed devices. The trade-off is a larger cybersecurity surface, making secure development, authentication, encryption, vulnerability management, software bills of materials, and patching processes critical to product acceptance.

Interoperability is another major innovation priority. Health systems want measurements to flow into the electronic health record without duplicate charting, into alarm-management systems without creating parallel alerts, and into virtual-care platforms without requiring separate credentials. Standards-based integration can reduce custom interface cost, but real-world deployments still require significant configuration. Vendors that provide implementation services, clinical workflow design, and ongoing interface support can outperform technically comparable products sold as stand-alone hardware.

Power management and ruggedization remain commercially important. Portable monitors must tolerate transport vibration, drops, cleaning chemicals, fluid exposure, and frequent movement between departments. Home devices must be simple enough for patients with limited technical confidence and robust enough to function across variable broadband conditions. Longer battery life, rapid charging, replaceable batteries, low-power wireless protocols, and reliable offline data storage can be decisive in emergency medical services, rural care, and hospital-at-home programs.

Manufacturers are also raising the bar through evidence generation. U.S. buyers increasingly expect studies that show reduced nursing time, fewer unplanned transfers, earlier intervention, lower readmission, improved patient mobility, or better monitoring adherence. Clinical accuracy studies remain essential, but economic evidence is becoming equally important. Companies that can quantify avoided manual observations, reduced length of stay, lower alarm burden, or improved capacity utilization will have a stronger value proposition than companies that rely primarily on feature comparisons.

Segmentation Insights

The U.S. Portable Patient Monitoring Devices Market is segmented on the basis of product type, application, end user, technology type, and region. The segments overlap clinically, but each has a distinct purchasing model, replacement cycle, regulatory profile, and source of recurring revenue.

By Product Type

• Portable multiparameter patient monitors represent the largest hospital-facing product category. These systems typically combine ECG, pulse oximetry, noninvasive blood pressure, temperature, respiratory rate, and optional capnography in a compact transportable platform. Demand is supported by emergency departments, operating rooms, post-anesthesia care, intensive care transport, medical-surgical units, and ambulance services. Growth is driven less by greenfield hospital construction than by replacement of aging fleets, wireless upgrades, cybersecurity requirements, and standardization across multi-hospital systems.
• Wearable and patch-based monitors are the fastest-growing product type. This subsegment includes wireless telemetry, adhesive biosensors, wrist-worn medical monitors, continuous vital-sign patches, and mobile sensors used in hospital and home settings. Wearables expand monitoring into lower-acuity beds and post-discharge programs while preserving mobility. Their economics depend on sensor duration, disposable cost, adherence, connectivity, and the ability to avoid non-actionable alarms. Vendors that combine the sensor with a clinically credible surveillance platform can capture more value than hardware-only suppliers.
• Handheld and spot-check monitors include compact vital-sign devices, pulse oximeters, handheld ECG systems, portable blood pressure monitors, temperature devices, and point-of-care units used for rapid assessment. They are widely deployed in physician offices, urgent care, home health, nursing facilities, retail clinics, school health, and community programs. The segment is price competitive, but medical-grade accuracy, durable construction, infection-control compatibility, and automatic data transfer support premium positioning.
• Ambulatory diagnostic monitoring devices include extended Holter systems, mobile cardiac telemetry, event monitors, ambulatory blood pressure monitors, and portable respiratory diagnostic devices. These products generate high-value diagnostic data over longer periods than an office visit. Cardiac monitoring is the dominant subsegment because intermittent arrhythmias require extended observation and established reimbursement supports clinical use. Competition is influenced by analysis turnaround time, report quality, physician workflow, patient wear time, and the proportion of monitoring data that can be processed without manual review.
• Connected home monitoring kits combine medical devices such as blood pressure cuffs, scales, pulse oximeters, thermometers, glucose devices, and portable ECG tools with a hub or mobile application. The device revenue per patient may be modest, but the addressable population is large and recurring replacement demand can be meaningful. Commercial success depends on logistics, ease of onboarding, multilingual support, cellular options, integration with care-management workflows, and the ability to maintain engagement beyond the first few weeks.

By Application

• Cardiovascular monitoring is the largest application segment. It includes ambulatory ECG, mobile cardiac telemetry, heart-rate monitoring, blood pressure monitoring, pulse oximetry, and hemodynamic assessment used for arrhythmia, hypertension, heart failure, ischemic disease, post-procedure surveillance, and medication management. Nearly half of U.S. adults have hypertension, and cardiovascular disease remains a leading mortality burden. The application benefits from established specialist workflows and clear clinical triggers for escalation.
• Respiratory monitoring includes pulse oximetry, respiratory-rate sensors, portable capnography, spirometry-linked monitoring, and selected wearable systems used for COPD, asthma, pneumonia, sleep-related risk, post-anesthesia care, and opioid safety. Demand is particularly strong in older populations, rural states with higher COPD prevalence, emergency care, and home programs. Respiratory rate is gaining attention as an early deterioration signal, creating opportunities for continuous wearable measurement beyond intermittent pulse oximetry.
• Metabolic and chronic disease monitoring includes connected glucose devices, blood pressure systems, weight scales, temperature monitoring, and multiparameter kits used in diabetes, renal disease, obesity-related care, and multimorbidity. The U.S. has approximately 40 million people with diabetes and more than 115 million adults with prediabetes, supporting a large long-term need for home physiologic measurement. Device adoption is strongest when data are linked to medication adjustment, coaching, or documented care-management actions.
• Acute, perioperative, and post-acute monitoring includes transport monitoring, procedural sedation, recovery-room surveillance, ward observation, and remote follow-up after discharge. This application is attractive because it connects capital equipment and recurring sensors across the entire episode of care. Hospitals evaluate whether portable systems can maintain monitoring continuity from preoperative assessment through procedure, recovery, transfer, discharge, and home observation without repeated device changes or data loss.
• Maternal, pediatric, and geriatric monitoring is a specialized growth area. Portable fetal and maternal devices, neonatal pulse oximetry, pediatric vital-sign monitors, infant monitoring systems, fall-related sensors, and simplified geriatric home devices require population-specific validation and usability. Growth is supported by high-risk pregnancy management, pediatric home care, aging-in-place, and caregiver demand for earlier warning. These markets are clinically sensitive and require careful claims, alarm design, and human-factors testing.

By End User

• Hospitals and integrated health systems are the dominant end users by revenue. They purchase portable multiparameter monitors, telemetry, wearable surveillance systems, transport monitors, capnography, spot-check devices, and enterprise connectivity. Large systems often use value analysis committees and multi-year contracts to standardize vendors. Their purchasing decisions depend on clinical evidence, cybersecurity, service support, consumable pricing, interoperability, fleet management, and the ability to scale across different acuity levels.
• Home healthcare and remote patient monitoring providers are the fastest-growing end-user group. These organizations deploy connected devices for hypertension, heart failure, diabetes, COPD, post-discharge recovery, and high-risk populations. The procurement model is different from hospital capital purchasing because devices must be shipped, provisioned, recovered, cleaned, and reassigned. Low setup failure, automatic data transmission, and rapid replacement are more important than advanced bedside display features.
• Physician practices, ambulatory clinics, and specialty centers are important users of handheld monitors, ambulatory ECG, blood pressure devices, portable pulse oximetry, and remote monitoring kits. Cardiology, primary care, pulmonology, endocrinology, nephrology, and oncology practices are prominent adopters. These buyers prioritize reimbursement support, simple patient enrollment, concise reports, and integration with existing practice-management and electronic-record systems.
• Emergency medical services, urgent care, and mobile health units require rugged, battery-efficient, transportable monitoring. Devices must perform during motion, variable temperature, limited space, and unreliable connectivity. EMS purchasers prioritize durability, rapid startup, defibrillator integration where relevant, waveform quality, and serviceability. Mobile clinics and disaster-response programs also value cellular connectivity and the ability to operate without a fixed hospital network.
• Skilled nursing facilities, rehabilitation centers, and long-term care providers represent an underpenetrated but strategically important segment. Residents are medically complex, staffing is constrained, and transfers to hospitals are costly. Portable monitoring can support earlier recognition of infection, respiratory decline, blood pressure instability, arrhythmia, dehydration, and post-acute complications. Adoption is constrained by limited capital budgets, fragmented IT infrastructure, and the need for clear escalation protocols.

By Technology Type

• Wireless portable monitors are becoming the leading technology architecture. Bluetooth, Wi-Fi, and proprietary low-power protocols support untethered monitoring within hospitals and homes. Wireless systems improve mobility and can reduce cable burden, but signal loss, interference, network coverage, and cybersecurity must be controlled. Hospitals increasingly test wireless performance under real clinical loads rather than relying on laboratory specifications.
• Cellular-connected monitoring is the fastest-growing technology type for home and mobile care. Embedded cellular connectivity reduces dependence on patient smartphones and broadband, improving activation rates in older, rural, and lower-income populations. The higher hardware and data cost can be justified when it reduces onboarding failure, technical support, and missing data. Multi-carrier capability and remote provisioning are becoming important procurement criteria.
• Sensor-based wearable technology includes adhesive electrodes, optical sensors, accelerometers, temperature sensors, impedance measurement, and other miniaturized components. These systems can generate continuous data with minimal patient interaction. Competitive differentiation depends on accuracy during movement, skin compatibility, wear duration, battery performance, and the ability to convert multiple raw signals into clinically interpretable metrics.
• AI-enabled monitoring and clinical decision support combine device data with trend analysis, risk scoring, and alert prioritization. The technology is moving from retrospective reporting toward real-time surveillance. Hospitals will demand transparent performance, governance, validation, and integration with clinical protocols. Algorithms that reduce alarm volume while maintaining sensitivity may create greater economic value than systems that simply add more predictive notifications.
• Cloud-integrated and interoperable platforms connect portable devices to electronic records, central monitoring stations, virtual-care hubs, and analytics environments. This technology type is essential for enterprise deployment because distributed devices create little value if data remain isolated. Growth will favor vendors that support standards-based integration, secure APIs, identity management, device lifecycle management, and auditable data flows across care settings.

Regional Insights: Where the Market is Growing Fastest

The U.S. Portable Patient Monitoring Devices Market is geographically segmented into the Northeast, Midwest, South, and West. Regional performance varies according to population growth, age structure, chronic disease prevalence, hospital concentration, rural access, telehealth adoption, integrated delivery network scale, and state-level investment in home and community care. The South is the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the most clinically intensive region per patient, and the Midwest provides a stable base of hospital, cardiac, respiratory, and rural monitoring demand.

South

The South accounted for an estimated USD 1.78 billion in 2025 and is projected to reach approximately USD 4.39 billion by 2035, representing a CAGR of about 9.45%. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, the District of Columbia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Its leadership is supported by the largest regional population, rapid growth in major metropolitan areas, high cardiovascular and metabolic disease burden, large rural populations, and expanding hospital-at-home and home health capacity.

Texas and Florida are the two largest state opportunities. Texas combines major academic and integrated health systems in Houston, Dallas-Fort Worth, Austin, and San Antonio with extensive rural and border-area access needs. The state supports demand for hospital transport monitors, telemetry, remote blood pressure, diabetes monitoring, ambulatory ECG, and cellular home kits. Florida’s large older population creates strong demand for cardiovascular, respiratory, fall-related, and post-acute monitoring, while high Medicare exposure makes reimbursement execution and documentation particularly important.

North Carolina, Georgia, Tennessee, and Virginia are high-growth markets due to population inflows, health system expansion, and strong academic medical centers. North Carolina has a meaningful concentration of research-oriented providers and rural care programs. Georgia and Tennessee combine large urban referral centers with high chronic disease burden. Virginia benefits from sophisticated integrated systems, defense and federal healthcare activity, and a mix of urban and rural monitoring needs. Maryland, Delaware, and the District of Columbia support high-acuity academic care, government-linked healthcare activity, and dense specialist networks.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have elevated burdens of hypertension, diabetes, heart disease, and COPD. COPD prevalence has historically been especially high in West Virginia and parts of Appalachia, increasing the need for portable pulse oximetry, respiratory-rate monitoring, capnography, and home surveillance. These states also face provider shortages and long travel distances, strengthening the case for cellular-connected devices. However, limited broadband, lower facility capital budgets, and fragmented care coordination can slow adoption unless vendors provide logistics and clinical-program support.

South Carolina and the coastal South are seeing population growth and retirement migration that increase demand for home monitoring and ambulatory care. Across the region, the most attractive strategy is a dual-market approach: enterprise platforms for large health systems and simplified, cellular-enabled kits for rural and community programs. The South will remain the largest market because it combines scale, disease burden, and care-access need, even though procurement pricing pressure is often stronger than in the Northeast or West.

West

The West represented an estimated USD 1.12 billion in 2025 and is projected to reach approximately USD 3.10 billion by 2035, expanding at a CAGR of about 10.70%, the fastest among the four regions. The region includes Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming, Alaska, California, Hawaii, Oregon, and Washington. Growth is driven by digital health adoption, strong technology ecosystems, large integrated delivery networks, rapid population growth in the Mountain West, and the need to serve geographically dispersed communities.

California is the largest western state market and one of the most influential national launch environments. Major systems in Los Angeles, San Diego, the Bay Area, and Sacramento evaluate wearable surveillance, virtual care, AI-enabled monitoring, ambulatory cardiac devices, and hospital-at-home technologies. The state also has a dense medtech and digital health ecosystem, enabling partnerships between device manufacturers, software developers, and provider organizations. California buyers are demanding on interoperability, privacy, evidence, and workflow integration, but successful adoption can influence national reference accounts.

Arizona, Nevada, Colorado, and Utah are high-growth state markets. Arizona and Nevada benefit from population growth and aging, creating demand for cardiovascular, respiratory, and post-acute monitoring. Colorado and Utah have sophisticated integrated health systems and strong adoption of telehealth and connected care. New Mexico, Idaho, Montana, and Wyoming have smaller populations but substantial rural-distance challenges, making cellular devices, remote monitoring, and portable systems for critical access hospitals commercially important.

Washington and Oregon are mature digital-health markets with strong health system integration and interest in centralized monitoring, virtual nursing, and home-based care. Alaska and Hawaii require reliable portable systems because of geographic isolation, transport complexity, and limited access to tertiary facilities outside major population centers. In these states, battery life, offline operation, ruggedization, and cellular or satellite-compatible workflows can matter more than advanced display features. The West’s above-market growth will be led by wearable monitoring, ambulatory diagnostics, AI-enabled surveillance, and enterprise platforms that extend across hospital and home settings.

Northeast

The Northeast accounted for an estimated USD 0.93 billion in 2025 and is forecast to reach approximately USD 2.25 billion by 2035, representing a CAGR of about 9.25%. The region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, and Pennsylvania. It has a high concentration of academic medical centers, specialty hospitals, clinical research, and complex patient populations. Revenue per deployment is often high because buyers adopt advanced monitoring, enterprise integration, and premium analytics, although market growth is moderated by mature infrastructure and slower population expansion.

New York is the largest state market in the region, supported by dense hospital networks, major academic centers, and high patient volumes. Portable monitoring is used across emergency department boarding, transport, perioperative care, telemetry, home care, and large ambulatory networks. Pennsylvania and New Jersey provide substantial hospital and cardiology demand, including ambulatory ECG, hypertension monitoring, respiratory surveillance, and post-acute programs. Health system consolidation in these states supports enterprise contracts but can lengthen procurement cycles.

Massachusetts is strategically important because of its academic institutions, medtech research, digital health companies, and early adoption of hospital-at-home and virtual care. Connecticut and Rhode Island have smaller populations but high provider density and significant older-adult demand. Maine, New Hampshire, and Vermont combine aging populations with rural access constraints, creating opportunities for home monitoring, connected blood pressure and pulse oximetry, portable cardiac devices, and critical access hospital solutions. Northeast buyers typically require strong evidence, cybersecurity documentation, and integration planning before broad rollout.

Midwest

The Midwest represented approximately USD 0.79 billion in 2025 and is expected to reach about USD 1.82 billion by 2035, a CAGR of roughly 8.85%. The region includes Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. Demand is supported by large community hospital networks, strong cardiac and pulmonary disease management needs, major integrated systems, and extensive rural service areas. Growth is steady rather than speculative, with buyers placing high value on reliability, service coverage, and total cost of ownership.

Illinois, Ohio, Michigan, and Minnesota are the largest state markets. Chicago supports a broad academic and community hospital ecosystem, while Ohio has several nationally recognized health systems and large cardiovascular service lines. Michigan has significant chronic disease and post-acute monitoring demand. Minnesota is strategically important because of its medical device heritage, payer-provider integration, and concentration of clinical expertise. Wisconsin, Indiana, and Missouri provide durable demand for portable hospital monitors, telemetry, ambulatory cardiac systems, and connected home devices.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller markets but a high strategic need for rural monitoring. Critical access hospitals, regional referral networks, home health agencies, and telehealth programs require devices that can operate with limited technical support and inconsistent connectivity. Cellular kits, remote device diagnostics, and centralized clinical review can improve the economics of serving low-density populations. The Midwest will remain a dependable market for replacement equipment and practical remote-monitoring programs, although price sensitivity and slower adoption of premium wearable platforms will keep growth below the West and South.

Key Market Players

The U.S. Portable Patient Monitoring Devices Competitive Landscape is moderately consolidated in hospital multiparameter monitoring and telemetry, but highly fragmented in wearable sensing, remote monitoring, ambulatory diagnostics, and connected home devices. Large medtech companies compete through enterprise platforms, installed-base relationships, service networks, and bundled contracting. Specialized companies compete through superior signal acquisition, longer wear duration, focused clinical workflows, and faster product iteration.

Competition is increasingly platform-based. Hospitals prefer vendors that can connect portable monitors, telemetry, central stations, alarm management, electronic records, mobile communication, and home monitoring. Home and ambulatory buyers place greater weight on patient onboarding, device logistics, cellular connectivity, report quality, and reimbursement support. Across both settings, cybersecurity, software lifecycle management, and supply reliability are becoming central to vendor selection.

Some of the key players in the U.S. Portable Patient Monitoring Devices industry are:

• GE HealthCare
• Philips
• Medtronic
• Danaher / Masimo
• Baxter International
• Dragerwerk
• Nihon Kohden
• Mindray
• Becton, Dickinson and Company
• Abbott Laboratories
• Dexcom
• Boston Scientific
• iRhythm Technologies
• ZOLL Medical
• Spacelabs Healthcare
• BioIntelliSense
• VitalConnect
• Nonin Medical
• Omron Healthcare
• Honeywell
• SCHILLER
• AliveCor
• ResMed
• Biotricity

GE HealthCare, Philips, Baxter, Nihon Kohden, Mindray, Drager, and Spacelabs have strong positions in hospital monitoring, transport, telemetry, and enterprise connectivity. Danaher, through Masimo, is positioned around pulse oximetry, advanced sensing, wearable vital-sign monitoring, and telemonitoring. Medtronic, BD, and ZOLL participate through specialized monitoring, capnography, acute-care, emergency, and hemodynamic technologies. Abbott, Dexcom, iRhythm, Boston Scientific, AliveCor, Biotricity, and ResMed are important in ambulatory cardiac, metabolic, respiratory, and chronic disease monitoring.

Market share through 2035 will be influenced by FDA clearances, enterprise contracting, sensor economics, interoperability, service quality, clinical evidence, cybersecurity maturity, and the ability to operate across care settings. Large incumbents will benefit from installed bases and procurement relationships, while focused innovators can win where they reduce patient burden, extend wear duration, improve data quality, or solve a specific workflow problem that broad platforms have not addressed effectively.

Recent Developments

Recent developments in the U.S. Portable Patient Monitoring Devices Market show accelerating convergence between hospital monitoring, wearable sensors, remote care, and enterprise software. In April 2024, GE HealthCare received FDA clearance for Portrait VSM, expanding its connected monitoring ecosystem with a portable vital-sign solution designed to support efficient patient assessment and data continuity. The development reflects a broader move by major vendors to connect spot-check and continuous monitoring rather than treating them as separate device categories.

Wearable monitoring also advanced in 2024. Masimo received FDA clearance for connectivity between its W1 medical watch and the SafetyNet telemonitoring platform, allowing continuous oxygen saturation and pulse-rate data to be reviewed remotely. Masimo also expanded wearable vital-sign monitoring through Radius VSM and related technologies. These developments demonstrate the commercial direction of the market: medical-grade sensing is moving onto smaller, untethered devices that can be used in hospitals and homes while maintaining clinician access to data.

In September 2025, Philips launched a next-generation smart telemetry platform with a compact wearable monitor designed to support patient mobility and enterprise-wide cardiac surveillance. The platform emphasizes scalable telemetry capacity and filtering of non-actionable alarms, two priorities for hospitals managing staffing pressure and fluctuating census. The launch also highlights the importance of central surveillance architecture rather than isolated wearable hardware.

Connected glucose monitoring continued to broaden the portable monitoring ecosystem. FDA clearance of Abbott’s Libre Rio over-the-counter continuous glucose monitoring system in 2024 and continued iterations of Dexcom’s G7 platform through 2025 and 2026 expanded access to factory-calibrated glucose data. Although full diabetes-management revenue extends beyond the strict scope of this report, these products influence expectations for device miniaturization, app integration, wear duration, direct-to-patient distribution, and continuous physiologic data.

Regulatory attention to cybersecurity intensified. The FDA issued updated final guidance in June 2025 on cybersecurity quality-system considerations and premarket submission content for cyber devices. In January 2025, the agency also warned about cybersecurity vulnerabilities in certain Contec and Epsimed patient monitors used in healthcare and home settings. These actions have direct procurement implications because hospitals increasingly require software bills of materials, patching commitments, vulnerability-disclosure processes, secure authentication, and lifecycle support before connecting portable monitors to enterprise networks.

Reimbursement and care-delivery policy continued to support market expansion. CMS guidance confirms that remote physiologic monitoring can be used for acute or chronic conditions, requires electronic collection and automatic secure upload, and requires the monitoring device to meet the FDA definition of a medical device. Updated coding structures that recognize shorter and longer data-collection periods can improve program flexibility, but providers must maintain medical necessity, patient consent, and compliant billing workflows.

The competitive landscape changed materially in 2026 when Danaher completed its approximately USD 9.9 billion acquisition of Masimo. Masimo now operates as a stand-alone company within Danaher’s diagnostics segment. The transaction gives Danaher a major position in pulse oximetry, advanced sensor technology, and AI-enabled acute-care monitoring, and may accelerate investment in integrated diagnostics and monitoring. It also increases competitive pressure on GE HealthCare, Philips, Baxter, and other enterprise vendors to strengthen sensor differentiation and connected-care portfolios.

U.S. health systems are also expanding enterprise monitoring contracts and hospital-at-home programs. More than 360 approved hospital facilities across over 130 health systems have participated in the CMS acute hospital care at home framework, creating demand for portable vital signs, cellular connectivity, remote escalation, and device logistics. The next competitive phase will focus on scaling from pilot programs to standardized operations with measurable outcomes, predictable per-patient cost, and integration into command centers and clinical documentation.

Conclusion

The U.S. Portable Patient Monitoring Devices Market Size & Share is positioned to expand from USD 4.62 billion in 2025 to approximately USD 11.56 billion by 2035, supported by a 9.60% CAGR during the forecast period. Growth is grounded in chronic disease burden, population aging, hospital labor pressure, expansion of lower-acuity and home-based care, reimbursement for remote physiologic monitoring, and continuous innovation in wireless sensing and ambulatory diagnostics.

The most attractive product opportunities will be wearable multiparameter monitors, ambulatory cardiac devices, connected pulse oximetry, cellular home-monitoring kits, portable capnography, and interoperable transport monitors. Mature spot-check and multiparameter systems will remain important, but value growth will increasingly shift toward recurring sensors, connectivity, analytics, and device-management capabilities. Manufacturers must control alarm burden and workflow complexity to convert technical innovation into sustainable adoption.

Hospitals will remain the largest end users, but home healthcare and remote monitoring providers will generate the fastest growth. Procurement decisions will be based on total episode economics, including nursing time, device logistics, consumable cost, connectivity failure, cybersecurity, integration, and clinical response. Vendors that can show reduced manual workload, earlier escalation, lower readmissions, or improved capacity utilization will be able to defend premium pricing more effectively than vendors offering measurement accuracy without workflow evidence.

Regional opportunity will be led by the South because of population scale, chronic disease burden, and access gaps. The West will grow fastest through adoption of wearable, AI-enabled, and virtual-care platforms. The Northeast will remain a premium market for advanced integrated monitoring and clinical validation, while the Midwest will provide stable replacement demand and a strong use case for rural and centralized monitoring. Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, Minnesota, Tennessee, and Virginia will be among the most commercially important state markets.

For clients evaluating this market, the central strategic question is not whether portable monitoring adoption will increase. The key questions are which devices will become embedded in reimbursable care pathways, which platforms will reduce clinician workload rather than add data burden, and which vendors can support secure deployment across hospital and home environments. Companies that combine medical-grade signal quality, patient-friendly design, enterprise interoperability, cybersecurity discipline, recurring sensor economics, and credible outcomes evidence will define the U.S. portable patient monitoring devices market through 2035.

TABLE OF CONTENT

1. U.S. Portable Patient Monitoring Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Analytical Frameworks & Forecasting Models
1.3.6. Data Triangulation, Validation and Final Report Publishing
1.4. Key Market Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Portable Patient Monitoring Device Manufacturers
1.6.2. Sensor, Semiconductor and Medical Component Suppliers
1.6.3. Contract Manufacturers and Original Design Manufacturers
1.6.4. Hospitals, Health Systems and Integrated Delivery Networks
1.6.5. Physician Practices, Specialty Clinics and Ambulatory Care Providers
1.6.6. Home Healthcare, Hospital-at-Home and Remote Monitoring Providers
1.6.7. Group Purchasing Organizations, Distributors and Durable Medical Equipment Suppliers
1.6.8. Commercial Payers, Medicare, Medicaid and Value-Based Care Organizations
1.6.9. FDA, CMS and Healthcare Technology Decision-Makers
What this section provides: This section defines the market boundary, study scope, methodology, assumptions and stakeholder ecosystem so clients understand how the U.S. Portable Patient Monitoring Devices Market is measured, segmented and validated.

2. U.S. Portable Patient Monitoring Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2021–2035, US$ Billion
2.8. High-Growth Product and Technology Opportunities
2.9. Priority Clinical Applications
2.10. Regional and State-Level Opportunity Summary
2.11. Competitive and Investment Highlights
What this section provides: This section gives decision-makers a concise view of market size, growth direction, key demand pockets, competitive intensity, technology priorities and high-value opportunities across the U.S. portable patient monitoring ecosystem.

3. U.S. Portable Patient Monitoring Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Cardiovascular, Respiratory and Metabolic Diseases
3.1.2. Growth of the U.S. Older Adult and Medically Complex Population
3.1.3. Expansion of Remote Patient Monitoring and Connected Care Programs
3.1.4. Hospital-at-Home and Early-Discharge Care Model Adoption
3.1.5. Increasing Demand for Continuous and Ambulatory Patient Surveillance
3.1.6. Emergency Department, Transport and Mobile Care Requirements
3.1.7. Nursing Workforce Constraints and Clinical Workflow Automation
3.1.8. Expansion of Medicare-Reimbursed Remote Physiological Monitoring
3.2. Restraints and Their Impact Analysis
3.2.1. High Cost of Advanced Multiparameter and Connected Monitoring Platforms
3.2.2. Reimbursement Variability Across Monitoring Use Cases
3.2.3. Cybersecurity, Data Privacy and Connected-Device Vulnerabilities
3.2.4. Alarm Fatigue and False-Positive Clinical Notifications
3.2.5. Interoperability Limitations Across Electronic Health Record Systems
3.2.6. Patient Adherence and Digital Literacy Barriers
3.2.7. Sensor Accuracy, Calibration and Performance Variability
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Enabled Clinical Deterioration Prediction
3.3.2. Wearable Multiparameter Monitoring Platforms
3.3.3. Cuffless Blood Pressure and Noninvasive Hemodynamic Monitoring
3.3.4. Hospital-at-Home Monitoring Infrastructure
3.3.5. Remote Monitoring for Chronic Disease Management
3.3.6. Rural Health and Underserved Population Monitoring
3.3.7. Consumer-Clinical Monitoring Convergence
3.3.8. Recurring Sensor, Software and Monitoring-Service Revenue Models
3.4. Challenges and Their Impact Analysis
3.4.1. Integration of Device Data into Clinical Workflows
3.4.2. Enterprise Standardization Across Diverse Care Settings
3.4.3. Clinician Capacity to Review High-Volume Monitoring Data
3.4.4. Demonstrating Reduction in Admissions and Total Cost of Care
3.4.5. Managing Hardware Replacement and Disposable Sensor Economics
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Total Cost of Ownership Analysis
3.9. Alarm Management and Clinical Escalation Workflow Analysis
3.10. Remote Monitoring Program Economics and Reimbursement Capture
What this section provides: This section explains the commercial, clinical, reimbursement, technological and operational forces shaping demand, helping clients evaluate market upside, adoption barriers and execution risks.

4. U.S. Portable Patient Monitoring Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Sensor and Semiconductor Supply
4.4.2. Medical-Grade Component Manufacturing
4.4.3. Device Assembly and Software Integration
4.4.4. Distribution, Installation and Clinical Training
4.4.5. Monitoring Services, Data Analytics and After-Sales Support
4.5. Impact of Digitalization and Connected Patient Monitoring
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. HIPAA, Cybersecurity and Patient Data Governance
4.10. Interoperability Standards and EHR Integration
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Initiatives and Public Health Programs
4.13. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.14. Hospital Value Analysis Committee Decision Framework
4.15. Device-as-a-Service and Subscription-Based Procurement Models
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chain, interoperability, cybersecurity, technology adoption and procurement dynamics.

5. U.S. Portable Patient Monitoring Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Portable Multiparameter Patient Monitors
5.1.2.1. Handheld Multiparameter Monitors
5.1.2.2. Transport and Bedside-to-Transport Monitors
5.1.2.3. Modular and Spot-Check Vital Signs Monitors
5.1.2.4. Compact Continuous Surveillance Monitors
5.1.3. Portable Cardiac Monitoring Devices
5.1.3.1. Portable and Handheld ECG Devices
5.1.3.2. Holter Monitoring Devices
5.1.3.3. Event Monitors and Mobile Cardiac Telemetry Systems
5.1.3.4. Wearable and Patch-Based ECG Monitors
5.1.3.5. Portable Defibrillator-Monitor Systems
5.1.4. Portable Respiratory Monitoring Devices
5.1.4.1. Handheld and Wearable Pulse Oximeters
5.1.4.2. Portable Capnography Monitors
5.1.4.3. Respiratory Rate Monitoring Devices
5.1.4.4. Portable Spirometry and Pulmonary Function Monitoring Devices
5.1.4.5. Sleep and Ambulatory Respiratory Monitoring Systems
5.1.5. Portable Hemodynamic and Vital Signs Monitoring Devices
5.1.5.1. Portable Blood Pressure Monitors
5.1.5.2. Ambulatory Blood Pressure Monitoring Devices
5.1.5.3. Portable Temperature Monitoring Devices
5.1.5.4. Noninvasive Hemodynamic Monitoring Devices
5.1.5.5. Portable Spot-Check Diagnostic Stations
5.1.6. Portable Metabolic and Specialty Monitoring Devices
5.1.6.1. Blood Glucose Monitoring Devices
5.1.6.2. Continuous Glucose Monitoring Systems
5.1.6.3. Portable Maternal, Fetal and Neonatal Monitoring Devices
5.1.6.4. Portable Neurological and Cerebral Monitoring Devices
5.1.6.5. Other Specialty Portable Monitoring Devices
What this section provides: This section identifies which portable monitoring device categories and subcategories are expected to generate the highest revenue contribution, strongest recurring demand and fastest growth through 2035.

6. U.S. Portable Patient Monitoring Devices Market – By Clinical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)
6.1.2. Cardiac and Arrhythmia Monitoring
6.1.2.1. Atrial Fibrillation Detection
6.1.2.2. Ambulatory ECG and Rhythm Surveillance
6.1.2.3. Post-Cardiac Procedure Monitoring
6.1.2.4. Heart Failure Monitoring
6.1.3. Respiratory and Sleep-Related Monitoring
6.1.3.1. Chronic Obstructive Pulmonary Disease Monitoring
6.1.3.2. Asthma and Respiratory Deterioration Monitoring
6.1.3.3. Sleep Apnea and Sleep-Disordered Breathing Monitoring
6.1.3.4. Postoperative Respiratory Monitoring
6.1.4. Hypertension and Hemodynamic Monitoring
6.1.4.1. Home Blood Pressure Monitoring
6.1.4.2. Ambulatory Blood Pressure Monitoring
6.1.4.3. Acute Hemodynamic Surveillance
6.1.4.4. Pregnancy-Related Hypertension Monitoring
6.1.5. Diabetes and Metabolic Monitoring
6.1.5.1. Type 1 Diabetes Monitoring
6.1.5.2. Type 2 Diabetes Monitoring
6.1.5.3. Gestational Diabetes Monitoring
6.1.5.4. Inpatient and Post-Discharge Glycemic Monitoring
6.1.6. Acute, Post-Acute and General Patient Surveillance
6.1.6.1. Emergency and Transport Monitoring
6.1.6.2. Perioperative and Recovery Monitoring
6.1.6.3. Post-Discharge Monitoring
6.1.6.4. Hospital-at-Home Monitoring
6.1.6.5. Elderly, Frailty and Long-Term Care Monitoring
What this section provides: This section helps clients understand demand by clinical use case and prioritize applications with strong patient volumes, reimbursement relevance, workflow impact and monitoring intensity.

7. U.S. Portable Patient Monitoring Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Acute-Care Hospitals
7.1.2.2. Academic Medical Centers
7.1.2.3. Community Hospitals
7.1.2.4. Critical Access Hospitals
7.1.2.5. Emergency Departments and Transport Services
7.1.3. Ambulatory and Outpatient Care Providers
7.1.3.1. Ambulatory Surgery Centers
7.1.3.2. Outpatient Hospital Departments
7.1.3.3. Urgent Care Centers
7.1.3.4. Dialysis and Infusion Centers
7.1.4. Physician Practices and Specialty Clinics
7.1.4.1. Cardiology Practices
7.1.4.2. Pulmonology and Sleep Clinics
7.1.4.3. Primary Care Practices
7.1.4.4. Endocrinology and Diabetes Clinics
7.1.4.5. Maternal and Fetal Care Centers
7.1.5. Home Healthcare and Remote Monitoring Providers
7.1.5.1. Home Health Agencies
7.1.5.2. Hospital-at-Home Programs
7.1.5.3. Remote Patient Monitoring Service Providers
7.1.5.4. Virtual Care and Telehealth Providers
7.1.5.5. Durable Medical Equipment Providers
7.1.6. Long-Term and Post-Acute Care Facilities
7.1.6.1. Skilled Nursing Facilities
7.1.6.2. Assisted Living Facilities
7.1.6.3. Rehabilitation Centers
7.1.6.4. Hospice and Palliative Care Providers
What this section provides: This section explains which care settings and customer groups are expected to drive device purchasing, recurring sensor consumption, monitoring-service adoption and enterprise platform deployment.

8. U.S. Portable Patient Monitoring Devices Market – By Technology and Connectivity Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology and Connectivity Type, 2025 & 2035 (%)
8.1.2. Handheld and Compact Monitoring Technologies
8.1.2.1. Standalone Handheld Monitors
8.1.2.2. Smartphone-Connected Monitoring Devices
8.1.2.3. Portable Diagnostic and Spot-Check Platforms
8.1.3. Wearable and Body-Worn Monitoring Technologies
8.1.3.1. Adhesive Patch-Based Sensors
8.1.3.2. Wrist-Worn and Arm-Worn Medical Devices
8.1.3.3. Chest-Worn Monitoring Devices
8.1.3.4. Textile and Garment-Integrated Sensors
8.1.4. Transportable Multiparameter Monitoring Technologies
8.1.4.1. Battery-Powered Transport Monitors
8.1.4.2. Modular Multiparameter Systems
8.1.4.3. Bedside-to-Transport Monitoring Platforms
8.1.5. Wireless and Cloud-Connected Monitoring Technologies
8.1.5.1. Bluetooth-Enabled Devices
8.1.5.2. Wi-Fi-Enabled Devices
8.1.5.3. Cellular-Connected Devices
8.1.5.4. Cloud-Based Remote Monitoring Platforms
8.1.5.5. EHR-Integrated Monitoring Systems
8.1.6. AI-Enabled and Software-Integrated Monitoring Technologies
8.1.6.1. Predictive Deterioration Analytics
8.1.6.2. Automated Arrhythmia and Event Detection
8.1.6.3. Intelligent Alarm Prioritization
8.1.6.4. Clinical Decision-Support Platforms
8.1.6.5. Digital Biomarker and Population Monitoring Analytics
What this section provides: This section evaluates the technology platforms shaping portable patient monitoring, including handheld devices, wearables, transport monitors, wireless connectivity, cloud infrastructure and AI-enabled clinical workflows.

9. U.S. Portable Patient Monitoring Devices Market – By Procurement and Distribution Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement and Distribution Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchasing
9.1.2.2. Department-Level Device Procurement
9.1.2.3. Consumable and Sensor Replenishment Contracts
9.1.2.4. Device-as-a-Service Agreements
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Enterprise Vendor Standardization
9.1.3.2. Multi-Hospital Purchasing Agreements
9.1.3.3. Connected Monitoring Platform Contracts
9.1.3.4. Outcomes-Based and Risk-Sharing Agreements
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional GPO Contracts
9.1.4.3. Aggregated Health System Purchasing
9.1.5. Distributor, DME and Specialty Supplier Sales
9.1.5.1. Medical Device Distributors
9.1.5.2. Durable Medical Equipment Suppliers
9.1.5.3. Home Healthcare Supply Companies
9.1.5.4. Pharmacy and Specialty Medical Retail Channels
9.1.6. Digital Health, Home-Care, Retail and E-Commerce Channels
9.1.6.1. Remote Monitoring Platform Procurement
9.1.6.2. Telehealth and Virtual Care Partnerships
9.1.6.3. Direct-to-Consumer Medical Device Sales
9.1.6.4. Retail Pharmacy Distribution
9.1.6.5. Online and E-Commerce Sales
What this section provides: This section helps clients understand how portable patient monitoring devices are purchased and distributed in the U.S., including hospital contracting, IDN standardization, GPO influence, distributor channels and home-monitoring procurement models.

10. U.S. Portable Patient Monitoring Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Patient Population and Chronic Disease Burden Analysis
10.1.4. Regional Hospital, Ambulatory and Home-Care Infrastructure Analysis
10.1.5. Regional Remote Patient Monitoring Adoption Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Connectivity, Rural Access and Digital Health Readiness
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Health Systems, Remote Monitoring Platforms and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Health Systems, Remote Monitoring Platforms and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Health Systems, Remote Monitoring Platforms and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Health Systems, Remote Monitoring Platforms and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology and Connectivity Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement and Distribution Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify priority U.S. geographies, chronic-disease demand pockets, connected-care adoption hotspots, hospital-at-home opportunities and state-level commercial potential.

11. U.S. Portable Patient Monitoring Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Market Leaders
11.2.2. Established Challengers
11.2.3. Digital Monitoring Innovators
11.2.4. Emerging and Specialized Players
11.3. Competitive Benchmarking
11.3.1. Product Portfolio Breadth
11.3.2. Clinical Application Coverage
11.3.3. Connectivity and Interoperability Capability
11.3.4. Installed Base and Health System Relationships
11.3.5. Remote Monitoring and Software Capabilities
11.3.6. U.S. Regulatory and Reimbursement Positioning
11.4. Company Profiles
11.4.1. Koninklijke Philips N.V.
11.4.2. GE HealthCare Technologies Inc.
11.4.3. Medtronic plc
11.4.4. Masimo Corporation
11.4.5. Baxter International Inc.
11.4.6. Nihon Kohden America, Inc.
11.4.7. Drägerwerk AG & Co. KGaA
11.4.8. Mindray North America
11.4.9. Abbott Laboratories
11.4.10. DexCom, Inc.
11.4.11. OMRON Healthcare, Inc.
11.4.12. ZOLL Medical Corporation
11.4.13. iRhythm Technologies, Inc.
11.4.14. Boston Scientific Corporation
11.4.15. AliveCor, Inc.
11.4.16. VitalConnect, Inc.
11.4.17. BioIntelliSense, Inc.
11.4.18. Spacelabs Healthcare
11.4.19. Nonin Medical, Inc.
11.4.20. Edwards Lifesciences Corporation
11.4.21. SCHILLER Americas Inc.
11.4.22. Natus Medical Incorporated
11.4.23. ICU Medical, Inc.
11.4.24. Withings Health Solutions
11.4.25. Current Health, a Best Buy Health Company
Note: Each company profile will include company overview, portable patient monitoring portfolio, U.S. market strategy, financial and commercial positioning, clinical and technology pipeline, FDA updates, interoperability capabilities, partnerships, acquisitions and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, connected-monitoring capabilities, innovation direction and strategic intelligence on leading portable patient monitoring companies.

12. U.S. Portable Patient Monitoring Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Enabled Deterioration Prediction
12.2.2. Multimodal Wearable Biosensors
12.2.3. Cuffless Blood Pressure Monitoring
12.2.4. Contactless and Camera-Based Patient Monitoring
12.2.5. Continuous Noninvasive Hemodynamic Monitoring
12.2.6. Digital Biomarkers and Personalized Alerting
12.2.7. Interoperable Hospital-at-Home Monitoring Platforms
12.2.8. Edge Computing and On-Device Clinical Analytics
12.3. Emerging Business Trends
12.3.1. Shift from Hardware Sales to Recurring Monitoring Revenue
12.3.2. Device-as-a-Service Adoption
12.3.3. Health System and Digital Health Partnerships
12.3.4. Consumer-Clinical Device Convergence
12.3.5. Enterprise Remote Monitoring Command Centers
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product White-Space Analysis
12.7. State and Regional Expansion Opportunities
What this section provides: This section prepares clients for future technology shifts, monitoring model changes, investment opportunities, new revenue structures and potential adoption scenarios through 2035.

13. U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations

13.1. Recommendations for Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Remote Monitoring and Hospital-at-Home Providers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors, DME Suppliers and Channel Partners
13.6. Recommendations for Commercial Payers and Value-Based Care Organizations
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Health System Contracting and GPO Strategy
13.11. Reimbursement, Evidence and Health Economics Strategy
13.12. Interoperability and Cybersecurity Strategy
What this section provides: This section converts market intelligence into actionable strategy for growth planning, product positioning, contracting, channel expansion, evidence generation, investment decisions and competitive differentiation.

14. U.S. Portable Patient Monitoring Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing and Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Reimbursement Change Disclaimer
14.7. Company and Competitive Information Disclaimer
What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, forecasting assumptions and potential effects of future regulatory, reimbursement and competitive changes.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Portable Patient Monitoring Devices Market: Market Definition and Scope
TABLE 3: U.S. Portable Patient Monitoring Devices Market: Research Methodology Framework
TABLE 4: U.S. Portable Patient Monitoring Devices Market: Key Assumptions
TABLE 5: U.S. Portable Patient Monitoring Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Portable Patient Monitoring Devices Market: Stakeholder Analysis
TABLE 7: U.S. Portable Patient Monitoring Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Portable Patient Monitoring Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Portable Patient Monitoring Devices Market: Market Attractiveness Index
TABLE 10: U.S. Portable Patient Monitoring Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Portable Patient Monitoring Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Portable Patient Monitoring Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Portable Patient Monitoring Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Portable Patient Monitoring Devices Market: High-Growth Opportunity Areas
TABLE 15: U.S. Portable Patient Monitoring Devices Market: Drivers; Impact Analysis
TABLE 16: U.S. Portable Patient Monitoring Devices Market: Restraints; Impact Analysis
TABLE 17: U.S. Portable Patient Monitoring Devices Market: Opportunities; Impact Analysis
TABLE 18: U.S. Portable Patient Monitoring Devices Market: Challenges; Impact Analysis
TABLE 19: U.S. Portable Patient Monitoring Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Portable Patient Monitoring Devices Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Portable Patient Monitoring Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Portable Patient Monitoring Devices Market: Total Cost of Ownership Analysis
TABLE 23: U.S. Portable Patient Monitoring Devices Market: Remote Monitoring Program Economics and Reimbursement Capture
TABLE 24: U.S. Portable Patient Monitoring Devices Market: PESTEL Analysis
TABLE 25: U.S. Portable Patient Monitoring Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Portable Patient Monitoring Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Portable Patient Monitoring Devices Market: Value Chain Analysis
TABLE 28: U.S. Portable Patient Monitoring Devices Market: Supply Chain Analysis
TABLE 29: U.S. Portable Patient Monitoring Devices Market: Digitalization and Connected Monitoring Impact
TABLE 30: U.S. Portable Patient Monitoring Devices Market: Application & Innovation Landscape
TABLE 31: U.S. Portable Patient Monitoring Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Portable Patient Monitoring Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 33: U.S. Portable Patient Monitoring Devices Market: HIPAA, Cybersecurity and Patient Data Governance
TABLE 34: U.S. Portable Patient Monitoring Devices Market: Interoperability Standards and EHR Integration
TABLE 35: U.S. Portable Patient Monitoring Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 36: U.S. Portable Patient Monitoring Devices Market: Government Initiatives and Public Health Programs
TABLE 37: U.S. Portable Patient Monitoring Devices Market: Impact of Geopolitical and Supply-Chain Tensions
TABLE 38: U.S. Portable Patient Monitoring Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 39: U.S. Portable Patient Monitoring Devices Market: Device-as-a-Service and Subscription Procurement Models
TABLE 40: U.S. Portable Patient Monitoring Devices Market: Product Category Snapshot, 2025
TABLE 41: Segment Dashboard; Definition and Scope, by Product Category
TABLE 42: U.S. Portable Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 43: U.S. Portable Patient Monitoring Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 44: U.S. Portable Patient Monitoring Devices Market: Portable Multiparameter Patient Monitors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Portable Patient Monitoring Devices Market: Portable Cardiac Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Portable Patient Monitoring Devices Market: Portable Respiratory Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Portable Patient Monitoring Devices Market: Portable Hemodynamic and Vital Signs Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Portable Patient Monitoring Devices Market: Portable Metabolic and Specialty Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Portable Patient Monitoring Devices Market: Clinical Application Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 51: U.S. Portable Patient Monitoring Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 52: U.S. Portable Patient Monitoring Devices Market: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 53: U.S. Portable Patient Monitoring Devices Market: Cardiac and Arrhythmia Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Portable Patient Monitoring Devices Market: Respiratory and Sleep-Related Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Portable Patient Monitoring Devices Market: Hypertension and Hemodynamic Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Portable Patient Monitoring Devices Market: Diabetes and Metabolic Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Portable Patient Monitoring Devices Market: Acute, Post-Acute and General Patient Surveillance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Portable Patient Monitoring Devices Market: End User Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by End User
TABLE 60: U.S. Portable Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 61: U.S. Portable Patient Monitoring Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 62: U.S. Portable Patient Monitoring Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Portable Patient Monitoring Devices Market: Ambulatory and Outpatient Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Portable Patient Monitoring Devices Market: Physician Practices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Portable Patient Monitoring Devices Market: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Portable Patient Monitoring Devices Market: Long-Term and Post-Acute Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Portable Patient Monitoring Devices Market: Technology and Connectivity Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by Technology and Connectivity Type
TABLE 69: U.S. Portable Patient Monitoring Devices Market, by Technology and Connectivity Type, 2021–2035 (US$ Billion)
TABLE 70: U.S. Portable Patient Monitoring Devices Market: Segment Share Analysis, by Technology and Connectivity Type, 2025 & 2035 (%)
TABLE 71: U.S. Portable Patient Monitoring Devices Market: Handheld and Compact Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Portable Patient Monitoring Devices Market: Wearable and Body-Worn Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Portable Patient Monitoring Devices Market: Transportable Multiparameter Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Portable Patient Monitoring Devices Market: Wireless and Cloud-Connected Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Portable Patient Monitoring Devices Market: AI-Enabled and Software-Integrated Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Portable Patient Monitoring Devices Market: Procurement and Distribution Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement and Distribution Channel
TABLE 78: U.S. Portable Patient Monitoring Devices Market, by Procurement and Distribution Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Portable Patient Monitoring Devices Market: Segment Share Analysis, by Procurement and Distribution Channel, 2025 & 2035 (%)
TABLE 80: U.S. Portable Patient Monitoring Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Portable Patient Monitoring Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Portable Patient Monitoring Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Portable Patient Monitoring Devices Market: Distributor, DME and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Portable Patient Monitoring Devices Market: Digital Health, Home-Care, Retail and E-Commerce Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Portable Patient Monitoring Devices Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Region
TABLE 87: U.S. Portable Patient Monitoring Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Portable Patient Monitoring Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: West Region U.S. Portable Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 90: West Region U.S. Portable Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 91: West Region U.S. Portable Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Portable Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Portable Patient Monitoring Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Portable Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Portable Patient Monitoring Devices Market, by Technology and Connectivity Type, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Portable Patient Monitoring Devices Market, by Procurement and Distribution Channel, 2021–2035 (US$ Billion)
TABLE 97: Northeast Region U.S. Portable Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 98: Northeast Region U.S. Portable Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 99: Northeast Region U.S. Portable Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 100: Northeast Region U.S. Portable Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Northeast Region U.S. Portable Patient Monitoring Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 102: Northeast Region U.S. Portable Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. Portable Patient Monitoring Devices Market, by Technology and Connectivity Type, 2021–2035 (US$ Billion)
TABLE 104: Northeast Region U.S. Portable Patient Monitoring Devices Market, by Procurement and Distribution Channel, 2021–2035 (US$ Billion)
TABLE 105: South Region U.S. Portable Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 106: South Region U.S. Portable Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 107: South Region U.S. Portable Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 108: South Region U.S. Portable Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 109: South Region U.S. Portable Patient Monitoring Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 110: South Region U.S. Portable Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 111: South Region U.S. Portable Patient Monitoring Devices Market, by Technology and Connectivity Type, 2021–2035 (US$ Billion)
TABLE 112: South Region U.S. Portable Patient Monitoring Devices Market, by Procurement and Distribution Channel, 2021–2035 (US$ Billion)
TABLE 113: Midwest Region U.S. Portable Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 114: Midwest Region U.S. Portable Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 115: Midwest Region U.S. Portable Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 116: Midwest Region U.S. Portable Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 117: Midwest Region U.S. Portable Patient Monitoring Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 118: Midwest Region U.S. Portable Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 119: Midwest Region U.S. Portable Patient Monitoring Devices Market, by Technology and Connectivity Type, 2021–2035 (US$ Billion)
TABLE 120: Midwest Region U.S. Portable Patient Monitoring Devices Market, by Procurement and Distribution Channel, 2021–2035 (US$ Billion)
TABLE 121: California Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Washington Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Arizona Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Colorado Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Oregon Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Utah Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Nevada Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Idaho Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Montana Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Wyoming Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Alaska Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Hawaii Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: New York Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Massachusetts Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: New Jersey Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Pennsylvania Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Connecticut Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Maine Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Vermont Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: New Hampshire Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Rhode Island Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Delaware Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Texas Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Florida Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Georgia Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: North Carolina Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Tennessee Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: South Carolina Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Alabama Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Mississippi Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Louisiana Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Arkansas Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Kentucky Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Oklahoma Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Virginia Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Maryland Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: West Virginia Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Illinois Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Ohio Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Michigan Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Minnesota Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Indiana Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Wisconsin Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Missouri Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Iowa Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Kansas Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Nebraska Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: North Dakota Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: South Dakota Portable Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: U.S. Portable Patient Monitoring Devices Market: Competitive Landscape Snapshot, 2025
TABLE 172: U.S. Portable Patient Monitoring Devices Market: Key Company Market Share Analysis, 2025
TABLE 173: U.S. Portable Patient Monitoring Devices Market: Company Positioning Matrix
TABLE 174: U.S. Portable Patient Monitoring Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 175: U.S. Portable Patient Monitoring Devices Market: Connectivity and Interoperability Benchmarking
TABLE 176: U.S. Portable Patient Monitoring Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 177: Koninklijke Philips N.V.: Company Profile
TABLE 178: GE HealthCare Technologies Inc.: Company Profile
TABLE 179: Medtronic plc: Company Profile
TABLE 180: Masimo Corporation: Company Profile
TABLE 181: Baxter International Inc.: Company Profile
TABLE 182: Nihon Kohden America, Inc.: Company Profile
TABLE 183: Drägerwerk AG & Co. KGaA: Company Profile
TABLE 184: Mindray North America: Company Profile
TABLE 185: Abbott Laboratories: Company Profile
TABLE 186: DexCom, Inc.: Company Profile
TABLE 187: OMRON Healthcare, Inc.: Company Profile
TABLE 188: ZOLL Medical Corporation: Company Profile
TABLE 189: iRhythm Technologies, Inc.: Company Profile
TABLE 190: Boston Scientific Corporation: Company Profile
TABLE 191: AliveCor, Inc.: Company Profile
TABLE 192: VitalConnect, Inc.: Company Profile
TABLE 193: BioIntelliSense, Inc.: Company Profile
TABLE 194: Spacelabs Healthcare: Company Profile
TABLE 195: Nonin Medical, Inc.: Company Profile
TABLE 196: Edwards Lifesciences Corporation: Company Profile
TABLE 197: SCHILLER Americas Inc.: Company Profile
TABLE 198: Natus Medical Incorporated: Company Profile
TABLE 199: ICU Medical, Inc.: Company Profile
TABLE 200: Withings Health Solutions: Company Profile
TABLE 201: Current Health, a Best Buy Health Company: Company Profile
TABLE 202: U.S. Portable Patient Monitoring Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 203: U.S. Portable Patient Monitoring Devices Market: Disruptive Technologies Impact Matrix
TABLE 204: U.S. Portable Patient Monitoring Devices Market: Emerging Business Trends
TABLE 205: U.S. Portable Patient Monitoring Devices Market: Business Opportunities for Startups and Existing Players
TABLE 206: U.S. Portable Patient Monitoring Devices Market: Investment Prioritization Matrix
TABLE 207: U.S. Portable Patient Monitoring Devices Market: Product White-Space Analysis
TABLE 208: U.S. Portable Patient Monitoring Devices Market: State and Regional Expansion Opportunities
TABLE 209: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 210: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 211: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Remote Monitoring and Hospital-at-Home Providers
TABLE 212: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 213: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Distributors, DME Suppliers and Channel Partners
TABLE 214: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for Commercial Payers and Value-Based Care Organizations
TABLE 215: U.S. Portable Patient Monitoring Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 216: U.S. Portable Patient Monitoring Devices Market: Go-to-Market Strategy Considerations
TABLE 217: U.S. Portable Patient Monitoring Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 218: U.S. Portable Patient Monitoring Devices Market: Reimbursement, Evidence and Health Economics Strategy
TABLE 219: U.S. Portable Patient Monitoring Devices Market: Interoperability and Cybersecurity Strategy
TABLE 220: U.S. Portable Patient Monitoring Devices Market: Scope Limitation
TABLE 221: U.S. Portable Patient Monitoring Devices Market: Data Use Limitation
TABLE 222: U.S. Portable Patient Monitoring Devices Market: Market Sizing and Forecasting Limitation
TABLE 223: U.S. Portable Patient Monitoring Devices Market: Legal Disclaimer
TABLE 224: U.S. Portable Patient Monitoring Devices Market: Third-Party Data Disclaimer
TABLE 225: U.S. Portable Patient Monitoring Devices Market: Regulatory and Reimbursement Change Disclaimer
TABLE 226: U.S. Portable Patient Monitoring Devices Market: Company and Competitive Information Disclaimer

List of Figures

FIGURE 1: U.S. Portable Patient Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Overview
FIGURE 4: Stakeholder Analysis
FIGURE 5: Value Chain Analysis
FIGURE 6: Supply Chain Analysis
FIGURE 7: PESTEL Analysis
FIGURE 8: Porter’s Five Forces Analysis
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: Clinical Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: Total Cost of Ownership Framework
FIGURE 15: U.S. Portable Patient Monitoring Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Portable Patient Monitoring Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 18: High-Growth Opportunity Map
FIGURE 19: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 20: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Portable Multiparameter Patient Monitors Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Portable Cardiac Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Portable Respiratory Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Portable Hemodynamic and Vital Signs Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Portable Metabolic and Specialty Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Clinical Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Cardiac and Arrhythmia Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Respiratory and Sleep-Related Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Hypertension and Hemodynamic Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Diabetes and Metabolic Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Acute, Post-Acute and General Patient Surveillance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Ambulatory and Outpatient Care Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Physician Practices and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Home Healthcare and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Long-Term and Post-Acute Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology and Connectivity Type Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology and Connectivity Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Handheld and Compact Monitoring Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Wearable and Body-Worn Monitoring Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Transportable Multiparameter Monitoring Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Wireless and Cloud-Connected Monitoring Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: AI-Enabled and Software-Integrated Monitoring Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Procurement and Distribution Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Procurement and Distribution Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Distributor, DME and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Digital Health, Home-Care, Retail and E-Commerce Channels Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Portable Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Northeast Region U.S. Portable Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 60: Northeast Region Market Share Analysis by State, 2025
FIGURE 61: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: South Region U.S. Portable Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 63: South Region Market Share Analysis by State, 2025
FIGURE 64: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Midwest Region U.S. Portable Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 66: Midwest Region Market Share Analysis by State, 2025
FIGURE 67: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: California Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Washington Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Arizona Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Colorado Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Oregon Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Utah Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Nevada Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New Mexico Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Idaho Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Montana Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Wyoming Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Alaska Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Hawaii Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New York Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Massachusetts Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New Jersey Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Pennsylvania Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Connecticut Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Maine Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Vermont Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: New Hampshire Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Rhode Island Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Delaware Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Texas Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Florida Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Georgia Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: North Carolina Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Tennessee Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: South Carolina Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Alabama Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Mississippi Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Louisiana Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Arkansas Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Kentucky Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Oklahoma Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Virginia Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Maryland Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: West Virginia Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota Portable Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product Portfolio Benchmarking
FIGURE 121: Connectivity and Interoperability Benchmarking
FIGURE 122: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 123: Portable Patient Monitoring Innovation Roadmap
FIGURE 124: AI-Enabled Deterioration Prediction Adoption Roadmap
FIGURE 125: Wearable Multiparameter Monitoring Opportunity Map
FIGURE 126: Hospital-at-Home Monitoring Growth Roadmap
FIGURE 127: Future Market Scenario Analysis, 2026–2035
FIGURE 128: Disruptive Technologies Impact Matrix
FIGURE 129: Emerging Business Trends Matrix
FIGURE 130: Investment Prioritization Matrix
FIGURE 131: Product White-Space Opportunity Map
FIGURE 132: Strategic Growth Roadmap for U.S. Portable Monitoring Companies
FIGURE 133: Go-to-Market Strategy Framework
FIGURE 134: Product Positioning and Portfolio Expansion Framework
FIGURE 135: Reimbursement and Evidence Development Framework
FIGURE 136: Interoperability and Cybersecurity Strategy Framework
FIGURE 137: Report Scope and Disclaimer Framework